Landmark study offers new insights into what protects against dengue
Researchers have identified specific 'EDE-like' antibodies that may be crucial for developing broad, cross-serotype immunity against the dengue virus. This discovery offers a potential breakthrough in overcoming the complex immune challenges that have hindered universal vaccine development.
Why it matters
Dengue remains a major global health threat, and understanding these immune mechanisms is essential for creating effective, long-term vaccines.
The specific components of the immune response in a human body that protect against a dengue virus (DENV) infection and the subsequent illness remain unclear. Scientists are still trying to understand how natural infection and vaccination protect people so that they can develop better vaccines .
Scientific reporting based on peer-reviewed findings without subjective commentary.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in